Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

417
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
417
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
T Cell Types and Functions01:24

T Cell Types and Functions

1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surveillance for rubella virus in samples obtained from non-immunodeficient individuals.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2024
Same author

Kagami Ogata syndrome: a small deletion refines critical region for imprinting.

NPJ genomic medicine·2024
Same author

A patient with Pitt-Hopkins syndrome with concomitant common variable immunodeficiency.

American journal of medical genetics. Part A·2023
Same author

Rubella virus chronic inflammatory disease and other unusual viral phenotypes in inborn errors of immunity.

Immunological reviews·2023
Same author

Respiratory Comorbidities Associated with Bronchiectasis in Patients with Common Variable Immunodeficiency in the USIDNET Registry.

Journal of clinical immunology·2023
Same author

Delayed post-COVID-19 hemophagocytic lymphohistiocytosis in patient with XIAP deficiency.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2023

Related Experiment Video

Updated: Jun 25, 2025

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.1K

Ras-associated autoimmune lymphoproliferative disorder.

Kathleen E Sullivan1, Michele Lambert2

  • 1Division of Allergy Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

British Journal of Haematology
|May 26, 2024
PubMed
Summary

Distinguishing Reactive Angioendotheliomatosis and Myeloid Leukemia (RALD) from Juvenile Myelomonocytic Leukemia (JMML) is challenging. This review clarifies their distinct clinical features, genetic causes, and treatment approaches.

Keywords:
autoimmune diseaseleukaemiamyeloid leukaemiaspleen

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

419
Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

134.7K

Related Experiment Videos

Last Updated: Jun 25, 2025

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.1K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

419
Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

134.7K

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Genetics

Background:

  • Juvenile Myelomonocytic Leukemia (JMML) is a rare childhood leukemia.
  • Distinguishing JMML from other conditions, such as Reactive Angioendotheliomatosis and Myeloid Leukemia (RALD), presents diagnostic challenges.
  • Accurate differentiation is crucial for appropriate patient management.

Purpose of the Study:

  • To compare and contrast the clinical presentations of RALD and JMML.
  • To elucidate the distinct genetic etiologies underlying RALD and JMML.
  • To outline the common and unique treatment strategies for both conditions.

Main Methods:

  • Review of existing literature on RALD and JMML.
  • Comparative analysis of clinical, genetic, and therapeutic data.
  • Synthesis of information to highlight diagnostic and management distinctions.

Main Results:

  • RALD and JMML exhibit overlapping yet distinct clinical manifestations.
  • Specific genetic mutations are associated with each diagnosis, aiding differentiation.
  • Treatment protocols vary based on the specific diagnosis, with some shared therapeutic principles.

Conclusions:

  • Clinical and genetic profiling are essential for accurately distinguishing RALD from JMML.
  • Tailored treatment approaches based on precise diagnosis improve patient outcomes.
  • Further research is warranted to refine diagnostic criteria and therapeutic strategies.